FDA inspection

District Of Columbia Genrl Hsp: FDA inspection ending Feb 21, 2001

FDA inspection 62344 · No Action Indicated (NAI) · Washington, DC

Key facts

Inspection ID	62344
Firm	District Of Columbia Genrl Hsp
FEI number	1170175
Address	19th & Massachuset Ave Se
City	Washington
State	DC
ZIP	20003
Fiscal year	2001
Inspection end date	Feb 21, 2001
Classification	No Action Indicated (NAI)
Project area	Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products
Product type	Biologics

At a glance

None Citations
None Posted citations
No Warning letter followed
Yes Form FDA 483 issued
No Establishment inspection report (EIR) exists
1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections